Whistleblowers in the cancer field may expose a wide range of issues, including but not limited to:
- Fraudulent Research: Instances where research data is manipulated or fabricated to achieve desired outcomes. - Misconduct: Unethical behavior by medical professionals, such as knowingly recommending ineffective treatments. - Financial Conflicts of Interest: Situations where financial incentives might compromise the integrity of cancer research or treatment. - Unsafe Practices: Use of treatments or drugs that have not been adequately tested or have known harmful effects. - Patient Exploitation: Overcharging patients or recommending unnecessary treatments for financial gain.
